⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Halozyme Therapeutics, Inc.

$110.00
-0.38 (-0.34%)

Market Capitalization:

$12.48B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Halozyme Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

*No Trades in Segment

Regular Trading Hours

*No Trades in Segment

Premarket

*No Trades in Segment

After Hours Yesterday

-0.40(-0.36%)
Open$110.40
Close$110.00
Low$110.00
Low Change-0.40 (-0.36%)
High$110.65
High Change+0.25 (+0.23%)
Range$0.65
Volume1.697M
Dollar Volume$186.69M

Regular Trading Hours Yesterday

-1.16(-1.04%)
Open$111.54
Close$110.38
Low$110.35
Low Change-1.19 (-1.07%)
High$112.45
High Change+0.91 (+0.82%)
Range$2.10
Volume1.757M
Dollar Volume$193.91M

Premarket Yesterday

+0.00(+0.00%)
Open$111.55
Close$111.55
Low$111.50
Low Change-0.05 (-0.04%)
High$111.95
High Change+0.40 (+0.36%)
Range$0.45
Volume5.459K
Dollar Volume$608.95K

Halozyme Therapeutics Top Trades

We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.

Halozyme Therapeutics Moving Averages

5 Day Moving Average (SMA5)$112.78
10 Day Moving Average (SMA10)$112.51
20 Day Moving Average (SMA20)$110.42
50 Day Moving Average (SMA50)$101.78
100 Day Moving Average (SMA100)$86.94
200 Day Moving Average (SMA200)$77.88

Halozyme Therapeutics Statistics

Average Volume (30 Days)2.13M
P/E Ratio (Current)30.65
EPS (Current)$3.64
Dividend Yield0.00%
Free Cash Flow$806.22M
Cash Ratio0.47
Current Ratio2.71
Quick Ratio2.31
Debt to Equity14.95
Enterprise Value$14.65B
EV to EBITDA14.01
EV to Sales8.80
Price to Book88.21
Price to Cash Flow15.47
Price to Free Cash Flow15.71
Price to Sales7.61
Return on Assets0.16%
Return on Equity2.88%

Halozyme Therapeutics Stock Splits

There have been no stock splits for Halozyme Therapeutics (HALO).

Halozyme Therapeutics Dividends

There have been no dividends for Halozyme Therapeutics (HALO).